<https://rdf.molmedb.upol.cz/reference/ref311> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target86>;
	<http://purl.org/ontology/bibo/pmid> "19963380"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2009.11.053"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target112>,
		<https://identifiers.org/molmedb/MM17352>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW.: Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine. Bioorg Med Chem Lett, Volume 20 (2), 2010"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra31581> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref311> .
<https://rdf.molmedb.upol.cz/transporter/tra31580> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref311> .